INmune Bio, Inc.
NASDAQ:INMB
7.82 (USD) • At close April 25, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -42.082 | -30.008 | -27.299 | -30.34 | -12.099 | -7.678 | -12.44 | -0.831 | -0.277 | -0.049 |
| Depreciation & Amortization
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 7.605 | 7.368 | 7.149 | 4.796 | 3.112 | 4.097 | 10.001 | 0.2 | 0 | 0.12 |
| Change In Working Capital
| 1.037 | 10.436 | -2.864 | -3.086 | 0.044 | -0.261 | 0.38 | 0.02 | -0.09 | 0.001 |
| Accounts Receivables
| 1.033 | 6.019 | -2.957 | -3.705 | -1.153 | 0.002 | -0.32 | -0.067 | -0.26 | 0 |
| Inventory
| 0 | 0 | 2.957 | 3.705 | 1.153 | -0.002 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0 | 2.721 | 1.402 | 2.261 | 1.075 | -0.132 | 0.514 | 0.239 | 0.22 | 0 |
| Other Working Capital
| 0.004 | 1.696 | -4.266 | -5.347 | -1.032 | -0.129 | -0.134 | -0.219 | -0.31 | 0.001 |
| Other Non Cash Items
| 0.079 | 0.224 | 0.328 | 0.126 | 3.19 | -1.542 | 9.807 | -0.15 | 0.05 | 0.03 |
| Operating Cash Flow
| -33.361 | -11.98 | -22.686 | -28.504 | -8.944 | -5.385 | -2.059 | -0.762 | -0.317 | -0.018 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | -15 | 0 | 0 | 0 | -0.1 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | -15 | 0 | 0 | 0 | -0.1 | 0 | 0 |
| Investing Cash Flow
| 0 | 0 | 0 | -15 | 0 | 0 | 0 | -0.1 | 0 | 0 |
| Financing Activities: | ||||||||||
| Debt Repayment
| -10 | -5 | 0 | 14.951 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 27.789 | 0.775 | 0.699 | 80.253 | 24.907 | 12.209 | 0.9 | 2.056 | 0.1 | 0.03 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | -1.012 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.422 | 0 | 0.03 | 1.153 | 0 | 0 | 0 | 0 | 0.35 | 0.12 |
| Financing Cash Flow
| 18.211 | -4.225 | 0.729 | 96.357 | 23.895 | 12.209 | 0.9 | 2.056 | 0.45 | 0.03 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0.224 | -0.1 | -0.7 | -0.01 | 0.019 | -0.015 | -0.026 | 0.035 | -0.003 | 0 |
| Net Change In Cash
| -14.926 | -16.305 | -22.657 | 52.843 | 14.971 | 6.809 | -1.185 | 1.229 | 0.13 | 0.012 |
| Cash At End Of Period
| 20.922 | 35.848 | 52.153 | 74.81 | 21.967 | 6.996 | 0.186 | 1.371 | 0.142 | 0.012 |